Ovid Therapeutics (OVID) Net Equity Issued and Repurchased (2019 - 2026)
Ovid Therapeutics' (OVID) quarterly Net Equity Issued and Repurchased came in at $1000.0 in Q2 2026, down 99.96% quarter-over-quarter from $2.4 million in Q1 2026.
Analysis
Ovid Therapeutics (OVID) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends
Ovid Therapeutics (OVID) has reported Net Equity Issued and Repurchased for 4 consecutive years, with $1000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $1000.0; the trailing twelve-month figure through Jun 2026 stood at $2.4 million (up 11005.38% YoY), and the FY2020 full-year result was $46.7 million, down 27.12% from the prior year.
- Net Equity Issued and Repurchased fell to $1000.0 in Q2 2026 per OVID's latest filing, from $2.4 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $2.4 million in Q1 2026 and bottomed at $1000.0 in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | - |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | - |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | - |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | - |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | 141.90 Mn |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | - |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | - |
| 10 | Ovid Therapeutics | 517.32 Mn | 400.10 Mn | - | 1,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Mar 31, 2026 | 2.37 Mn |
| Dec 31, 2021 | 21,314.00 |
| Mar 31, 2021 | -21,314.00 |
| Dec 31, 2020 | -221,065.00 |
| Jun 30, 2020 | 8,368.00 |
| Mar 31, 2020 | -67,575.00 |
| Dec 31, 2019 | 33.60 Mn |
| Jun 30, 2019 | -391,885.00 |
| Mar 31, 2019 | 30.91 Mn |